会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • METHODS AND SYSTEMS FOR IDENTIFICATION OF MACROMOLECULES
    • 用于鉴定大分子的方法和系统
    • WO2005088302A1
    • 2005-09-22
    • PCT/US2005/005524
    • 2005-02-22
    • PROTEOGENIX, INC.NAGALLA, SrinivasaSEARLE, BrianDASARI, SurendraTURNER, Mark, A.
    • NAGALLA, SrinivasaSEARLE, BrianDASARI, SurendraTURNER, Mark, A.
    • G01N33/48
    • G06F19/22G06F19/28H01J49/0036
    • A method is provided for identifying sequences of molecules and sequence modifications form mass spectrometry data. At least one de novo sequence is produced from mass spectrometry data of sequences of molecules. A least one mass-based alignment is calculated between each de novo sequence and sequences in a sequence database. The molecular masses of molecules in the de novo sequence are compared to molecular masses of molecules in each sequence in the sequence database. Mass differences of modification sites are interpreted between the sequence in the sequence database and the novo sequence that have been identified by the mass-based alignment as modifications identified in a modification catalog. At least one match score for the mass-based alignment is calculated that provides an indication of matching between the sequence in the sequence database and the novo sequence. Sequences in the sequence database are identified from mass-based alignments in response to the match scores. Identifications of the sequence database are grouped from at least one de novo sequence into an identified macromolecule list that agrees with the novo sequencing results.
    • 提供了用于鉴定分子序列和形成质谱数据的序列修饰的方法。 由分子序列的质谱数据产生至少一个从头序列。 在序列数据库中的每个从头序列和序列之间计算至少一个基于质量的比对。 将从头序列中的分子的分子质量与序列数据库中的每个序列中的分子的分子量进行比较。 修饰位点的质量差异在序列数据库中的序列和通过基于质量的校准被鉴定为在修改目录中确定的修饰的新离子序列之间进行了解释。 计算用于基于质量的比对的至少一个匹配得分,其提供序列数据库中的序列和新诗序列之间的匹配的指示。 序列数据库中的序列根据匹配分数从基于质量的比对中确定。 序列数据库的识别从至少一个从头序列分组到与新呼号测序结果一致的识别的大分子列表中。
    • 9. 发明申请
    • PROTEOMIC ANALYSIS OF BIOLOGICAL FLUIDS
    • 生物流体的保护性分析
    • WO2008063928A9
    • 2008-07-17
    • PCT/US2007084311
    • 2007-11-09
    • PROTEOGENIX INCROSENFELD RONNAGALLA SRINIVASAGRAVETT MIKE
    • ROSENFELD RONNAGALLA SRINIVASAGRAVETT MIKE
    • G01N33/50G01N33/68
    • G01N33/689G01N2800/368Y02A90/26
    • The invention concerns the identification of proteomes of biological fluids and their use in determining the state of maternal/fetal conditions, including maternal conditions of fetal origin, chromosomal aneuploidies, and fetal diseases associated with fetal growth and maturation. In particular, the invention concerns a comprehensive proteomic analysis of human amniotic fluid (AF) and cervical vaginal fluid (CVF), and the correlation of characteristic changes in the normal proteome with various pathologic maternal/fetal conditions, such as intra-amniotic infection, pre-term labor, and/or chromosomal defects. The invention further concerns the identification of biomarkers and groups of biomarkers that can be used for non-invasive diagnosis of various pregnancy-related disorders, and diagnostic assays using such biomarkers.
    • 本发明涉及生物流体蛋白质组学的鉴定及其在确定母体/胎儿状况的用途,包括胎儿来源的母亲条件,染色体非整倍体和与胎儿生长和成熟相关的胎儿疾病。 特别地,本发明涉及人类羊水(AF)和子宫颈阴道液(CVF)的综合蛋白质组学分析,以及正常蛋白质组特征变化与各种病理性母体/胎儿状况的相关性,例如羊膜内感染, 前期劳动和/或染色体缺陷。 本发明还涉及可用于各种妊娠相关疾病的非侵入性诊断的生物标志物和生物标志物组的鉴定,以及使用这种生物标志物的诊断测定。
    • 10. 发明申请
    • PROTEOMIC ANALYSIS OF BIOLOGICAL FLUIDS
    • 生物流体的蛋白质组学分析
    • WO2008063928A2
    • 2008-05-29
    • PCT/US2007/084311
    • 2007-11-09
    • PROTEOGENIX, INC.ROSENFELD, RonNAGALLA, SrinivasaGRAVETT, Mike
    • ROSENFELD, RonNAGALLA, SrinivasaGRAVETT, Mike
    • G01N33/50
    • G01N33/689G01N2800/368Y02A90/26
    • The invention concerns the identification of proteomes of biological fluids and their use in determining the state of maternal/fetal conditions, including maternal conditions of fetal origin, chromosomal aneuploidies, and fetal diseases associated with fetal growth and maturation. In particular, the invention concerns a comprehensive proteomic analysis of human amniotic fluid (AF) and cervical vaginal fluid (CVF), and the correlation of characteristic changes in the normal proteome with various pathologic maternal/fetal conditions, such as intra-amniotic infection, pre-term labor, and/or chromosomal defects. The invention further concerns the identification of biomarkers and groups of biomarkers that can be used for non-invasive diagnosis of various pregnancy-related disorders, and diagnostic assays using such biomarkers.
    • 本发明涉及生物流体的蛋白质组的鉴定和它们在确定母体/胎儿状况(包括胎儿起源的母体状况,染色体非整倍体和与胎儿生长和成熟有关的胎儿疾病)中的用途 。 具体而言,本发明涉及人羊水(AF)和宫颈阴道液(CVF)的全面蛋白质组学分析,并且正常蛋白质组中的特征变化与各种病理性母/胎状况(例如羊膜内感染) 早产,和/或染色体缺陷。 本发明进一步涉及可用于非侵入性诊断各种妊娠相关病症的生物标志物和生物标志物组的鉴定,以及使用此类生物标志物的诊断测定。